Regarding safety, cemiplimab’s adverse event (AE) profile was manageable and consistent with those established among PD-1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback